Surrey Heartlands

Joint Formulary & PAD

Caffeine citrate - Neonatal apnoea

You are here : Home > Formulary Search > Caffeine citrate - Neonatal apnoea

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Infusion
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
R
SPC
Restrictions / Comments :
Important
Neonatal team only. State dose in terms of caffeine citrate to avoid risk of dosing errors. Caffeine citrate 2 mg = caffeine base 1 mg. Ampoules for intravenous infusion or oral administration.
 

Status 2

Red
Formulations :
  • Oral solution
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
R
SPC
Restrictions / Comments :
Important
Neonatal team only. Bioavailability of the oral solution is almost 100%. State dose in terms of caffeine citrate to avoid risk of dosing errors. Caffeine citrate 2 mg = caffeine base 1 mg Ampoules for intravenous infusion or oral administration.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Caffeine citrate
Indication :
Neonatal apnoea
Group Name :
Keywords :
Brand Names Include :
Peyona, Fenapin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Caffeine citrate is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Neonatal apnoea.

Committee Recommendations (1)

06 Nov 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.